Cboe Global Markets, Inc. CBOE ← Back to all reports

Cboe Global Markets, Inc.

CBOE · Financials
A ★★★★ Buy
Aug 4, 2026 · Score 87 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $310.23
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $300.00 ($290.00–$310.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $365.75
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+17.9%

Type A - Cboe Global Markets, Inc. (CBOE) 20260804 Stock Analysis

📅 Cboe Key Upcoming Events

🏢 Step 1: Cboe Company Overview & Business Model

Q1-A1. What is Cboe?

Q1-A2. How Does Cboe Make Money?

Q1-A3. Cboe’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Cboe’s Competitors?

Q1-A5. Cboe Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Cboe’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Cboe Have a Durable Economic Moat?

Q2-A2. Is Cboe’s Growth Sustainable?

Q2-A3. How Does Cboe Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Cboe Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Cboe? (Margins & ROIC)

Q3-A3. What Drives Cboe’s Returns? (ROIC Breakdown)

Q3-A4. Are Cboe’s Earnings High Quality?

Q3-A5. Is Cboe’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Cboe Forensic Accounting & Dilution Review

Q4-A1. Does Cboe Have Accounting Red Flags?

Q4-A2. Is Cboe Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Cboe’s Cash Flow?

Q4-A4. Is Cboe Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Cboe Management & Shareholder Alignment

Q5-A1. Can You Trust Cboe’s Management? (Guidance Track Record)

Q5-A2. What Are Cboe Insiders Doing?

Q5-A3. Is Cboe’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Cboe Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Cboe Guidance

Q6-A2. What Is Cboe’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Cboe Catalysts & Price Triggers

Q7-A1. What Could Move Cboe Stock? (Top 3 Catalysts)

Q7-A2. Cboe’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Cboe Fairly Valued? Valuation Analysis

Q8-A1. Cboe’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Cboe vs Peers: Valuation Comparison

Q8-A3. Is Cboe Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Cboe? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Cboe? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Cboe’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Cboe? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Cboe?

Q9-A2. How Sensitive Is Cboe to the Economy?

Q9-A3. Cboe Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Cboe Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Cboe? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Cboe’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Cboe’s Heavy Reliance on Proprietary SPX Options Its Biggest Weakness?

Q2: Can Cboe’s 24x Forward P/E Be Justified by the Structural Shift to 0DTE Trading?

Q3: How Will the Divestiture of the Australian and Canadian Exchanges Impact Long-Term Capital Efficiency?

Q4: What Systemic Risks Do Retail-Driven Zero-Day Options Pose to the OCC and Cboe’s Clearing Infrastructure?

Q5: Can Cboe Sustain Elite 70% Operating Margins Amid Rising Technological and Regulatory Costs?

Q6: How Formidable Is the Threat from Emerging Equity Options Exchanges Like MEMX and IEX?

Q7: Will the Expansion of Global Trading Hours (GTH) Meaningfully Accelerate Asian and European Institutional Volume?

Q8: What Impact Will S&P Dow Jones Indices’ SPX Licensing Extension to 2033 Have on Cboe’s Long-Term Pricing Power?

Q9: Can the Cboe Data Vantage Segment Maintain Double-Digit Growth as Alternative Market Data Sources Proliferate?

Q10: How Will Craig Donohue’s Leadership Pivot Cboe Toward the Prediction Markets Ecosystem?